메뉴 건너뛰기




Volumn 44, Issue 4, 2017, Pages 488-492

Correction: Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients (Journal of Rheumatology (2017) DOI: 10.3899/jrheum.160871);Anti-HMGCR autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients

(106)  Tansley, Sarah L a,b   Betteridge, Zoe E b   Simou, Stefania c   Jacques, Thomas S c   Pilkington, Clarissa d,o   Wood, Mark d,k   Warrier, Kishore e,n   Wedderburn, Lucy R c,f,o   McHugh, Neil J b   Armon, Kate g   Ellis Gage, Joe g   Roper, Holly g   Briggs, Vanja g   Watts, Joanna g   McCann, Liza h   Roberts, Ian h   Baildam, Eileen h   Hanna, Louise h   Lloyd, Olivia h   Wadeson, Susan h   more..


Author keywords

PEDIATRIC DERMATOMYOSITIS POLYMYOSITIS; PEDIATRIC RHEUMATIC DISEASES AUTOANTIBODIES; PROGNOSIS

Indexed keywords

CREATINE KINASE; CYCLOPHOSPHAMIDE; ENZYME ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE ANTIBODY; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; PREDNISOLONE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTOANTIBODY; HMGCR PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

EID: 85016930024     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.160871.C1     Document Type: Erratum
Times cited : (54)

References (14)
  • 1
    • 82955247611 scopus 로고    scopus 로고
    • Necrotizing autoimmune myopathy
    • Liang C, Needham M. Necrotizing autoimmune myopathy. Curr Opin Rheumatol 2011;23:612-9.
    • (2011) Curr Opin Rheumatol , vol.23 , pp. 612-619
    • Liang, C.1    Needham, M.2
  • 2
    • 79953711138 scopus 로고    scopus 로고
    • Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy
    • Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713-21.
    • (2011) Arthritis Rheum , vol.63 , pp. 713-721
    • Mammen, A.L.1    Chung, T.2    Christopher-Stine, L.3    Rosen, P.4    Rosen, A.5    Doering, K.R.6
  • 3
    • 84900452213 scopus 로고    scopus 로고
    • Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: Inconstant exposure to statin
    • Allenbach Y, Drouot L, Rigolet A, Charuel JL, Jouen F, Romero NB, et al. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine 2014;93:150-7.
    • (2014) Medicine , vol.93 , pp. 150-157
    • Allenbach, Y.1    Drouot, L.2    Rigolet, A.3    Charuel, J.L.4    Jouen, F.5    Romero, N.B.6
  • 4
    • 79951704680 scopus 로고    scopus 로고
    • A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; The Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies
    • Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, et al; Juvenile Dermatomyositis Research Group. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology 2011;50:137-45.
    • (2011) Rheumatology , vol.50 , pp. 137-145
    • Martin, N.1    Krol, P.2    Smith, S.3    Murray, K.4    Pilkington, C.A.5    Davidson, J.E.6
  • 5
    • 84925222840 scopus 로고    scopus 로고
    • Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset
    • Tansley SL, Betteridge ZE, Shaddick G, Gunawardena H, Arnold K, Wedderburn LR, et al. Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset. Rheumatology 2014;53:2204-8.
    • (2014) Rheumatology , vol.53 , pp. 2204-2208
    • Tansley, S.L.1    Betteridge, Z.E.2    Shaddick, G.3    Gunawardena, H.4    Arnold, K.5    Wedderburn, L.R.6
  • 6
    • 84903413902 scopus 로고    scopus 로고
    • Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: A prospective cohort study
    • Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C, et al; UK Juvenile Dermatomyositis Research Group. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther 2014;16:R138.
    • (2014) Arthritis Res Ther , vol.16 , pp. R138
    • Tansley, S.L.1    Betteridge, Z.E.2    Gunawardena, H.3    Jacques, T.S.4    Owens, C.M.5    Pilkington, C.6
  • 8
    • 84919386324 scopus 로고    scopus 로고
    • Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease
    • Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, et al; UK Juvenile Dermatomyositis Research Group. Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Ann Rheum Dis 2015;74:204-10.
    • (2015) Ann Rheum Dis , vol.74 , pp. 204-210
    • Varsani, H.1    Charman, S.C.2    Li, C.K.3    Marie, S.K.4    Amato, A.A.5    Banwell, B.6
  • 9
    • 35348820755 scopus 로고    scopus 로고
    • International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: A tool for potential use in clinical trials
    • Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, et al; UK Juvenile Dermatomyositis Research Group. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. Arthritis Rheum 2007; 57:1192-201.
    • (2007) Arthritis Rheum , vol.57 , pp. 1192-1201
    • Wedderburn, L.R.1    Varsani, H.2    Li, C.K.3    Newton, K.R.4    Amato, A.A.5    Banwell, B.6
  • 10
    • 33749639881 scopus 로고    scopus 로고
    • The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) - Clinical characteristics of children recruited within the first 5 yr
    • McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, et al; Juvenile Dermatomyositis Research Group. The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) - clinical characteristics of children recruited within the first 5 yr. Rheumatology 2006;45:1255-60.
    • (2006) Rheumatology , vol.45 , pp. 1255-1260
    • McCann, L.J.1    Juggins, A.D.2    Maillard, S.M.3    Wedderburn, L.R.4    Davidson, J.E.5    Murray, K.J.6
  • 12
    • 2342500841 scopus 로고    scopus 로고
    • Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies
    • Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, et al; Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004;50:1595-603.
    • (2004) Arthritis Rheum , vol.50 , pp. 1595-1603
    • Huber, A.M.1    Feldman, B.M.2    Rennebohm, R.M.3    Hicks, J.E.4    Lindsley, C.B.5    Perez, M.D.6
  • 14
    • 84927759355 scopus 로고    scopus 로고
    • Necrotizing myopathies: Beyond statins
    • Mammen AL. Necrotizing myopathies: beyond statins. Curr Opin Rheumatol 2014;26:679-83.
    • (2014) Curr Opin Rheumatol , vol.26 , pp. 679-683
    • Mammen, A.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.